SCHEMBL7312816

SCHEMBL7312816

CC(C)CC(NC(=O)c1cc(=O)c2ccccc2o1)C(=O)NC(Cc1ccccc1)C(=O)CSCc1ccco1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 3/20 0.53
LMNA P02545 1/20 0.42
PSMB1 P20618 1/20 0.42
PSMB5 P28074 1/20 0.42
PSMB2 P49721 1/20 0.42
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
CSNK2A3 Q8NEV1 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
CTSK P43235 1/20 0.39
CTSL P07711 1/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7312803 1.00 CAPN1 (0.53) CAPN1LMNAPSMB1PSMB5PSMB2
SCHEMBL7349928 0.93 CAPN1 (0.61) CAPN1LMNACSNK2A2CSNK2BCSNK2A1
SCHEMBL7349908 0.93 CAPN1 (0.61) CAPN1LMNACSNK2A2CSNK2BCSNK2A1
SCHEMBL7305250 0.91 TAS1R3 (0.52) CAPN1LMNAPSMB1PSMB5PSMB2
SCHEMBL8885687 0.89 CAPN1 (0.42) CAPN1LMNATAS1R3TAS1R1CSNK2A2
SCHEMBL8885698 0.89 CAPN1 (0.42) CAPN1LMNATAS1R3TAS1R1CSNK2A2
SCHEMBL7300779 0.83 REN (0.51) PSMB1PSMB5PSMB2REN
SCHEMBL7300785 0.83 REN (0.51) PSMB1PSMB5PSMB2REN
SCHEMBL7305262 0.83 PSMB5 (0.43) PSMB1PSMB5PSMB2POLBCTSL
SCHEMBL7300546 0.82 PSMB5 (0.60) PSMB1PSMB5PSMB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525420-B1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors MITSUBISHI CHEM CORP (JP) 1999-05-12 EP disclosed
US-5639783-A POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-06-17 US disclosed
EP-0525420-A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors Mitsubishi Chemical Corporation (JP) 1993-02-03 EP disclosed